Publications

• Total Neoadjuvant Therapy for Operable Pancreatic Cancer.

  (Kim RY, Christians KK, Aldakkak M, Clarke CN, George B, Kamgar M, Khan AH, Kulkarni N, Hall WA, Erickson BA, Evans DB, Tsai S.) Ann Surg Oncol. 2021 Apr;28(4):2246-2256 PMID: 33000372 SCOPUS ID: 2-s2.0-85091728559 10/02/2020

• Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology.

  (Glide-Hurst CK, Lee P, Yock AD, Olsen JR, Cao M, Siddiqui F, Parker W, Doemer A, Rong Y, Kishan AU, Benedict SH, Li XA, Erickson BA, Sohn JW, Xiao Y, Wuthrick E.) Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):1054-1075 PMID: 33470210 SCOPUS ID: 2-s2.0-85100531472 01/21/2021

• Cost-effectiveness analysis of universal germline testing for patients with pancreatic cancer.

  (Krepline AN, Geurts JL, George B, Kamgar M, Madhavan S, Erickson BA, Hall WA, Griffin MO, Evans DB, Tsai S, Kim RY.) Surgery. 2021 03;169(3):629-635 PMID: 32826069 SCOPUS ID: 2-s2.0-85089521842 08/23/2020

• NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update.

  (Small W Jr, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, Mell LK, Portelance L, Powell ME, Viswanathan AN, Yacoub JH, Yashar CM, Winter KA, Gaffney DK.) Int J Radiat Oncol Biol Phys. 2021 Feb 01;109(2):413-424 PMID: 32905846 PMCID: PMC7856050 09/10/2020

• Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods.

  (Mora J, Krepline AN, Aldakkak M, Christians KK, George B, Hall WA, Erickson BA, Kulkarni N, Evans DB, Tsai S.) Am J Surg. 2020 Dec 03 PMID: 33308823 SCOPUS ID: 2-s2.0-85097458297 12/15/2020

• A Patient-Specific Autosegmentation Strategy Using Multi-Input Deformable Image Registration for Magnetic Resonance Imaging-Guided Online Adaptive Radiation Therapy: A Feasibility Study.

  (Zhang Y, Paulson E, Lim S, Hall WA, Ahunbay E, Mickevicius NJ, Straza MW, Erickson B, Li XA.) Adv Radiat Oncol. 2020 Nov-Dec;5(6):1350-1358 PMID: 33305098 PMCID: PMC7718500 12/12/2020

• The ASTRO clinical practice guidelines in cervical cancer: Optimizing radiation therapy for improved outcomes.

  (Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, Fitch J, Harkenrider MM, Holschneider CH, Kamrava M, Leung E, Lin LL, Mayadev JS, Morcos M, Nwachukwu C, Petereit D, Viswanathan AN.) Gynecol Oncol. 2020 12;159(3):607-610 PMID: 32972783 SCOPUS ID: 2-s2.0-85091215036 09/26/2020

• The ABS brachytherapy schools.

  (Erickson B, Crook J, Vicini F, Arthur D, Ouhib Z, Thomadsen B, Bice W, Butler WM, Petereit DG, Viswanathan AN.) Brachytherapy. 2020 Nov - Dec;19(6):820-826 PMID: 32928682 SCOPUS ID: 2-s2.0-85090752266 09/16/2020

• A Patient-Specific Autosegmentation Strategy Using Multi-Input Deformable Image Registration for Magnetic Resonance Imaging–Guided Online Adaptive Radiation Therapy: A Feasibility Study

  (Zhang Y, Paulson E, Lim S, Hall WA, Ahunbay E, Mickevicius NJ, Straza MW, Erickson B, Li XA.) Advances in Radiation Oncology. 1 November 2020;5(6):1350-1358 SCOPUS ID: 2-s2.0-85097125143 11/01/2020

• The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy.

  (de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Sahgal A, Sarmiento JG, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Hall WA, Verkooijen HM.) Front Oncol. 2020;10:1328 PMID: 33014774 PMCID: PMC7505056 10/06/2020

• The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy

  (de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Sahgal A, Sarmiento JG, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Hall WA, Verkooijen HM.) Frontiers in Oncology. 7 September 2020;10 SCOPUS ID: 2-s2.0-85091425211 09/07/2020